|
gptkbp:instanceOf
|
gptkb:chemical_compound
recreational drug
|
|
gptkbp:alsoKnownAs
|
gptkb:Eve
gptkb:3,4-methylenedioxy-N-ethylamphetamine
|
|
gptkbp:category
|
amphetamine
|
|
gptkbp:chemicalFormula
|
C11H15NO2
|
|
gptkbp:controlledSubstanceSchedule
|
true
|
|
gptkbp:discoveredIn
|
early 20th century
|
|
gptkbp:drugClass
|
entactogen
stimulant
empathogen
|
|
gptkbp:effect
|
empathy
euphoria
increased sociability
stimulation
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:firstSynthesized
|
gptkb:Merck
1912
|
|
gptkbp:hasInChIKey
|
QZQOTICQVMEQAI-UHFFFAOYSA-N
|
|
gptkbp:hasSMILES
|
CCNC(CC1=CC2=C(C=C1)OCO2)C
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MDEA
|
|
gptkbp:IUPACName
|
gptkb:N-ethyl-1-(1,3-benzodioxol-5-yl)propan-2-amine
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
|
|
gptkbp:mainStreet
|
gptkb:Eve
MDE
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
193.24 g/mol
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL108187
19147
18077
|
|
gptkbp:relatedTo
|
gptkb:MDA
gptkb:MDMA
|
|
gptkbp:riskFactor
|
addiction
overdose
neurotoxicity
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
|
|
gptkbp:sideEffect
|
nausea
anxiety
insomnia
jaw clenching
|
|
gptkbp:UNII
|
1W7F1G3F1Q
|
|
gptkbp:usedFor
|
recreational purposes
|
|
gptkbp:bfsParent
|
gptkb:Methylenedioxyamphetamine
|
|
gptkbp:bfsLayer
|
6
|